Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Connect Bio Raises $191 Million in NASDAQ IPO for Autoimmune Portfolio

Taicang's Connect Biopharma Files for $100 Million NASDAQ IPO

SciClone IPOs on Hong Kong Exchange, Raising $279 Million

New Horizon Stages $263 Million HK IPO for Cancer Screening Tests

Microport Cardioflow Completes $324 Million HK IPO for Heart Valve Devices

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021